Deutsche Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Deutsche Bank's ELV Position: Q2 2026 in Review
Deutsche Bank increased its Elevance Health (ELV) stake by 2.1% in Q2 2026, buying an estimated $7.28M and bringing the position to 943,054 shares worth $365M. The position accounts for 0.11% of the portfolio, ranked #183.
Deutsche Bank first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $522M in Q4 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Deutsche Bank held 943,054 shares of Elevance Health worth $365M as of Q2 2026.
- Deutsche Bank bought 19,631 Elevance Health shares in Q2 2026, an estimated $7.28M.
- Elevance Health made up 0.11% of Deutsche Bank's portfolio in Q2 2026, its #183 holding.
- Deutsche Bank first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Elevance Health position peaked at $522M in Q4 2022.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.